Tag Archives: IONS

Top 10 Safest Stocks To Own Right Now

Gold doesn't trade in a vacuum.   Markets are connected. What happens in one often affects others.   So if you want to understand what's happening with gold, you need to know what's going on in the markets that affect gold.   And while lots of traders focus only on the short term, it's important to have a big-picture view, too. The big picture shows you the long-term trends at work… and when they change. It can help you find low-risk opportunities to open new positions. And it can help you determine where to set your stops.   Today, we'll look at the big picture for two markets that affect gold… along with gold itself.   Let's get started…   The first market we'll look at is U.S. government bonds… specifically, the yield on 10-year U.S. Treasurys. The U.S. government is considered the world's safest borrower. (It can print money to pay lenders back, after all.) The rate it pays to borrow money for 10 years serves as the world's benchmark interest rate.

Top 10 Safest Stocks To Own Right Now: Beasley Broadcast Group Inc.(BBGI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Beasley Broadcast Group (NASDAQ:BBGI) Director Mark S. Fowler sold 5,505 shares of the company’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $10.78, for a total value of $59,343.90. Following the sale, the director now owns 34,199 shares of the company’s stock, valued at $368,665.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Top 10 Safest Stocks To Own Right Now: Equifax, Inc.(EFX)

Advisors’ Opinion:

  • [By Max Byerly]

    Legal & General Group Plc cut its position in Equifax Inc. (NYSE:EFX) by 11.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 550,710 shares of the credit services provider’s stock after selling 72,328 shares during the quarter. Legal & General Group Plc owned about 0.46% of Equifax worth $68,899,000 at the end of the most recent reporting period.

  • [By ]

    Walmart is trying out a similar tactic with pork supply chains in China, but it’s far from the only company dipping its toe in the space. Other companies are testing blockchain’s potential for their logistics — everything from airplane parts, cargo shipments, medical records and even digital identities for refugees who lack official documents. Imagine no longer having a social security card, but a digital identity that couldn’t be hacked. We wouldn’t have to worry about data breaches like the recent one at Equifax (NYSE: EFX).

  • [By Stephan Byrd]

    Traders sold shares of Equifax Inc. (NYSE:EFX) on strength during trading on Monday. $14.23 million flowed into the stock on the tick-up and $53.87 million flowed out of the stock on the tick-down, for a money net flow of $39.64 million out of the stock. Of all stocks tracked, Equifax had the 30th highest net out-flow for the day. Equifax traded up $1.29 for the day and closed at $128.53

  • [By Stephan Byrd]

    Victory Capital Management Inc. decreased its position in Equifax Inc. (NYSE:EFX) by 23.1% in the 1st quarter, Holdings Channel reports. The firm owned 18,673 shares of the credit services provider’s stock after selling 5,595 shares during the period. Victory Capital Management Inc.’s holdings in Equifax were worth $2,200,000 at the end of the most recent reporting period.

  • [By Michael A. Robinson]

    Just last year, there was saturation coverage of the WannaCry ransomware attacks. We also saw intense news accounts of the massive hack of the credit rating agency Equifax Inc. (NYSE: EFX) that compromised 145 million accounts.

  • [By Travis Hoium]

    Companies that get a bad reputation from consumers often do so because they don’t have to make their experience better to keep customers. Great examples of this are a cable company that operates as a monopoly in many areas, like Comcast (NASDAQ:CMCSA), or a bank you just can’t get away from, like Wells Fargo (NYSE:WFC). Or even a company with all kinds of data about you that doesn’t seem to manage that data carefully, like Equifax Inc. (NYSE:EFX). 

Top 10 Safest Stocks To Own Right Now: LGI Homes, Inc.(LGIH)

Advisors’ Opinion:

  • [By Tyler Crowe]

    Look, it’s no secret that the housing market is booming right now, and that many homebuilders are doing quite well. But even with this backdrop, it’s still astounding that LGI Homes (NASDAQ:LGIH) has been able to put up the numbers that it has recently. Forget double-digit growth — LGI was able to grow revenue by a staggering 72% compared to this time last year.

  • [By Joseph Griffin]

    Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

    Get LGI Homes alerts:

    Stay Cool with Active Stock: Nevro Corp. (NVRO),LGI Homes, Inc. (LGIH) (bitcoinpriceupdate.review) LGI Homes (LGIH) to Release Earnings on Tuesday (americanbankingnews.com) RSI Alert: LGI Homes (LGIH) Now Oversold (nasdaq.com) PHOTOS: New community adding to Charlotte region's pipeline of luxury homes (finance.yahoo.com)

    LGIH has been the topic of a number of recent research reports. Wedbush downgraded shares of LGI Homes from an “outperform” rating to a “neutral” rating and set a $73.00 price target on the stock. in a research note on Tuesday, April 10th. Zacks Investment Research upgraded shares of LGI Homes from a “sell” rating to a “hold” rating in a research note on Tuesday, July 24th. BidaskClub downgraded shares of LGI Homes from a “buy” rating to a “hold” rating in a research note on Thursday, May 24th. Finally, ValuEngine downgraded shares of LGI Homes from a “buy” rating to a “hold” rating in a research note on Monday, May 14th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $65.60.

  • [By Tyler Crowe]

    Three stocks on my watchlist that look incredibly cheap and will likely be high up on my next buy list are LGI Homes (NASDAQ:LGIH), U.S. Silica Holdings (NYSE:SLCA), and Transocean (NYSE:RIG). Here’s why they look compelling to me now and why Wall Street seems to be assigning them such modest valuations. 

  • [By ]

    Cramer was bearish on Grubhub (GRUB) , Sprint (S) , LG Homes (LGIH) , Acadia Pharmaceuticals (ACAD) , Pilgrim’s Pride (PPC) , Opko Health (OPK) , Alaska Air Group (ALK) and Winnebago Industries (WGO) .

  • [By Neha Chamaria, Jason Hall, and Dan Caplinger]

    So, when we asked three of our Motley Fool contributors to each name a stock that has doubled and still has room to grow, they picked lululemon athletica (NASDAQ:LULU), LGI Homes Inc (NASDAQ:LGIH), and XPO Logistics (NYSE:XPO). Here’s why.

Top 10 Safest Stocks To Own Right Now: Ionis Pharmaceuticals, Inc.(IONS)

Advisors’ Opinion:

  • [By Cory Renauer]

    If the benefit Pfizer’s drug provides isn’t anything to get worked up about, insurers could have another option to use as leverage in negotiations. Partners Ionis Pharmaceuticals (NASDAQ:IONS) and Akcea Therapeutics (NASDAQ:AKCA) earned approval for inotersen in the European Union in July, and the FDA is expected to make a decision this October.

  • [By Brian Orelli]

    Likewise, Biogen (NASDAQ:BIIB) and Ionis Pharmaceuticals (NASDAQ:IONS), which have the only SMA drug on the market, are feeling the heat from the promising data with shares down 5.6% and 7.3%, respectively.

  • [By Chris Lange]

    Akcea Therapeutics Inc. (NASDAQ: AKCA) shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) that they had received a marketing authorization approval from the European Commission (EC).

  • [By George Budwell]

    Biogen’s double-digit move higher last month stemmed from two material events:

    Biogen and partner Eisai reported encouraging midstage results for the experimental Alzheimer’s disease drug BAN2401. Specifically, the two companies reported that patients receiving the highest dose of the drug showed a slower rate of decline than those on placebo after 18 months. Biogen reported that sales of the spinal muscular atrophy drug Spinraza — co-owned by Ionis Pharmaceuticals (NASDAQ:IONS) — jumped by a staggering 108% in the second quarter from the same period a year ago.  

    Image source: Getty Images.

  • [By Chris Lange]

    Akcea Therapeutics Inc. (NASDAQ: AKCA) and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) were each crushed on Tuesday after each announced that it received a Complete Response Letter (CRL) from U.S. Food and Drug Administration (FDA).

Top 10 Safest Stocks To Own Right Now: Thor Industries Inc.(THO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Media headlines about Tahoe Resources (NYSE:TAHO) (TSE:THO) have been trending somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tahoe Resources earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned press coverage about the basic materials company an impact score of 45.5394950251654 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Asit Sharma]

    Thor Industries’ (NYSE:THO) fiscal 2018 third-quarter earnings, released on June 6, helped stem some of the company’s recent share price decline: After surging nearly 51% in 2017, Thor’s shares have lost one-third of their value year to date. As my colleague Dan Caplinger recently pointed out, the recreational vehicle, or RV, market remains strong, but investors are concerned about Thor’s near-term prospects, given that it’s coming off a period of phenomenal revenue growth. Below, I’ll analyze five points made in Thor’s earnings release and most recent quarterly “questions and answers” document, which provide context around its current earnings and outlook.

  • [By Daniel Miller]

    Another metric that bodes well for Winnebago is its total backlog; this increased by a healthy 36% compared to the prior year, to $193.1 million. That 36% increase looks even better when you consider that competitor Thor Industries (NYSE:THO) reported an 18% decline in its backlog during its recent quarterly conference call — although Thor Industries offered an explanation for the reduction.

  • [By Garrett Baldwin]

    Markets are cheering a major development in efforts to fix the ongoing trade conflict between the United States and China. According to Reuters, Chinese telecom giant ZTE has signed an agreement to get back into business with its American partners. The agreement will lift a ban by the U.S. Commerce Department that prevented China’s No. 2 telecommunications equipment from buying from U.S. suppliers. This is a major development, and one that signals progress among trade officials from both nations. There are now more job openings in the United States than available workers. This is the first time that the Department of Labor has documented this phenomenon. There are 6.7 million openings compared to the 6.4 million workers available to fill those positions. As a result, U.S. companies have been forced to increase compensation in order to attract talent. All of the positive economic development could come to a screeching halt should the U.S. experience the largest labor strike in a decade. Reports indicate that the Teamsters and the United Parcel Service (NYSE: UPS) are on a collision course that could result in a general strike. The union has announced that 260,000 UPS employees have authorized a strike should both sides fail to reach a labor deal by August 1. UPS is responsible for the transport of 6% of the nation’s gross domestic product.
    Three Stocks to Watch Today: TSLA, NOG, WFC
    Tesla Inc. (Nasdaq: TSLA) investors remain committed to giving Chairman Elon Musk more of their money. On Tuesday, shareholders struck down proposals that would have removed Musk from the chairman role and shaken up the board of directors. Both proposals failed. At the same shareholder event, Musk announced plans for Tesla to open a production facility in Shanghai and projected that his firm will likely produce 5,000 Model 3 vehicles per week by the end of June. In deal news, defense contractor Northrop Grumman (NYSE: NOG) has won U.S. antitrust approval to purchase rocket moto

  • [By Asit Sharma]

    Leading recreational vehicle (RV) manufacturer Thor Industries, Inc. (NYSE:THO) reported a drop in revenue, as well as deterioration in several key financial metrics, in its fiscal fourth-quarter 2018 earnings report issued Thursday before the markets opened. The unexpectedly tepid performance jarred Thor shares, which traded down nearly 15% early in the trading session following the earnings release. Let’s review headline numbers below and uncover why shareholders found the report distasteful:

  • [By Shane Hupp]

    TheStreet lowered shares of Tahoe Resources (NYSE:TAHO) (TSE:THO) from a c rating to a d+ rating in a report published on Tuesday.

    A number of other research analysts also recently weighed in on TAHO. Cantor Fitzgerald assumed coverage on Tahoe Resources in a research note on Wednesday, March 28th. They set a buy rating on the stock. Zacks Investment Research downgraded Tahoe Resources from a hold rating to a sell rating in a research note on Thursday, April 26th. ValuEngine downgraded Tahoe Resources from a sell rating to a strong sell rating in a research note on Monday, April 2nd. Finally, Credit Suisse Group downgraded Tahoe Resources from an outperform rating to a neutral rating in a research note on Friday, January 26th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. Tahoe Resources has an average rating of Hold.

Top 10 Safest Stocks To Own Right Now: Vanguard FTSE Developed Markets ETF (VEA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Integrated Investment Consultants LLC lifted its holdings in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA) by 2.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 193,347 shares of the company’s stock after buying an additional 4,783 shares during the period. Vanguard FTSE Developed Markets ETF comprises 3.3% of Integrated Investment Consultants LLC’s holdings, making the stock its 7th largest holding. Integrated Investment Consultants LLC’s holdings in Vanguard FTSE Developed Markets ETF were worth $8,295,000 as of its most recent SEC filing.

  • [By WWW.GURUFOCUS.COM]

    For the details of ETF Portfolio Partners, Inc.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ETF+Portfolio+Partners%2C+Inc.

    These are the top 5 holdings of ETF Portfolio Partners, Inc.Vanguard Total Stock Market (VTI) – 194,472 shares, 17.91% of the total portfolio. Shares added by 1.13%iShares Core U.S. Aggregate Bond (AGG) – 254,189 shares, 17.72% of the total portfolio. Shares added by 3.15%iShares Russell 1000 (IWB) – 98,181 shares, 9.78% of the total portfolio. Shares added by 0.56%Vanguard FTSE Developed Markets (VEA) – 322,914 shares, 9.08% of the total portfolio. Shares added by 1.20%iShares S&P 500 Value (IVE) – 108,531

  • [By Max Byerly]

    Pure Financial Advisors Inc. lessened its stake in VANGUARD TAX-MA/FTSE DEVELOPED MKTS (NYSEARCA:VEA) by 4.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 404,056 shares of the company’s stock after selling 20,568 shares during the quarter. VANGUARD TAX-MA/FTSE DEVELOPED MKTS accounts for 3.9% of Pure Financial Advisors Inc.’s investment portfolio, making the stock its 6th largest position. Pure Financial Advisors Inc.’s holdings in VANGUARD TAX-MA/FTSE DEVELOPED MKTS were worth $17,334,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Max Byerly]

    Heritage Way Advisors LLC increased its position in shares of VANGUARD TAX-MA/FTSE DEVELOPED MKTS (NYSEARCA:VEA) by 10.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 129,626 shares of the company’s stock after acquiring an additional 12,161 shares during the quarter. VANGUARD TAX-MA/FTSE DEVELOPED MKTS makes up approximately 4.1% of Heritage Way Advisors LLC’s holdings, making the stock its 2nd biggest holding. Heritage Way Advisors LLC’s holdings in VANGUARD TAX-MA/FTSE DEVELOPED MKTS were worth $5,561,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Sanctuary Wealth Management L.L.C. lifted its stake in shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA) by 0.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 673,046 shares of the company’s stock after acquiring an additional 1,571 shares during the period. Vanguard FTSE Developed Markets ETF accounts for approximately 25.1% of Sanctuary Wealth Management L.L.C.’s portfolio, making the stock its 2nd biggest holding. Sanctuary Wealth Management L.L.C.’s holdings in Vanguard FTSE Developed Markets ETF were worth $29,782,000 at the end of the most recent reporting period.

Top 10 Safest Stocks To Own Right Now: ServisFirst Bancshares, Inc.(SFBS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    ServisFirst Bancshares (NASDAQ:SFBS) Q1 2018 Earnings Conference CallApril 16, 2018 4:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on ServisFirst Bancshares (SFBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    ValuEngine upgraded shares of ServisFirst Bancshares (NASDAQ:SFBS) from a hold rating to a buy rating in a report published on Tuesday.

    Several other equities research analysts have also issued reports on SFBS. BidaskClub raised shares of ServisFirst Bancshares from a buy rating to a strong-buy rating in a report on Tuesday, April 24th. Hovde Group set a $44.00 price objective on shares of ServisFirst Bancshares and gave the stock a hold rating in a report on Tuesday, January 23rd. Zacks Investment Research raised shares of ServisFirst Bancshares from a hold rating to a buy rating and set a $49.00 price objective for the company in a report on Thursday, April 19th. Finally, Sandler O’Neill reaffirmed a hold rating and issued a $45.00 price objective on shares of ServisFirst Bancshares in a report on Wednesday, March 28th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. ServisFirst Bancshares presently has a consensus rating of Hold and a consensus price target of $44.00.

  • [By Shane Hupp]

    Hilton Capital Management LLC cut its stake in ServisFirst Bancshares, Inc. (NASDAQ:SFBS) by 19.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,405 shares of the financial services provider’s stock after selling 2,245 shares during the period. Hilton Capital Management LLC’s holdings in ServisFirst Bancshares were worth $384,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Safest Stocks To Own Right Now: Valspar Corporation (VAL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of ValiRx Plc (LON:VAL) rose 5.6% during mid-day trading on Thursday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 587,748 shares were traded during trading, a decline of 85% from the average daily volume of 3,820,000 shares. The stock had previously closed at GBX 1.80 ($0.02).

  • [By Stephan Byrd]

    Valorbit (CURRENCY:VAL) traded up 0% against the U.S. dollar during the 1 day period ending at 0:00 AM E.T. on June 18th. One Valorbit coin can now be bought for approximately $0.0001 or 0.00000001 BTC on popular exchanges. Valorbit has a total market capitalization of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last day. During the last week, Valorbit has traded 5.8% higher against the U.S. dollar.

  • [By Max Byerly]

    Valorbit (CURRENCY:VAL) traded 0% higher against the dollar during the 1 day period ending at 11:00 AM Eastern on June 9th. One Valorbit coin can currently be bought for approximately $0.0001 or 0.00000001 BTC on exchanges. Valorbit has a market cap of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last 24 hours. In the last seven days, Valorbit has traded up 5.8% against the dollar.

Top 10 Safest Stocks To Own Right Now: MGIC Investment Corporation(MTG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about MGIC Investment (NYSE:MTG) have been trending somewhat positive on Monday, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. MGIC Investment earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned news headlines about the insurance provider an impact score of 45.4136127704926 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    Radian Group (NYSE: RDN) and MGIC Investment (NYSE:MTG) are both mid-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations and institutional ownership.

  • [By Dan Caplinger]

    Monday was a positive day on Wall Street, as major benchmarks jumped following an uneventful weekend, tapering their gains as the session came to a close. Some had feared that China might retaliate once again after the U.S. issued a second round of tariffs against the nation with the world’s second-largest economy, but the expected fireworks didn’t come, putting market participants more at ease. The beginning of earnings season in the next week will also distract investors from geopolitical issues, perhaps allowing indexes to climb further. Yet some individual stocks had difficulties that sent their shares lower. Yandex (NASDAQ:YNDX), Menlo Therapeutics (NASDAQ:MNLO), and MGIC Investment (NYSE:MTG) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Ethan Ryder]

    Headlines about MGIC Investment (NYSE:MTG) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MGIC Investment earned a coverage optimism score of 0.09 on Accern’s scale. Accern also gave news coverage about the insurance provider an impact score of 46.9053330399122 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Paul Ausick]

    MGIC Investment Corp. (NYSE: MTG) traded down about 5.2% Tuesday to post a new 52-week low of $10.07 after closing Monday at $10.62. The stock’s 52-week high is $16.21. Volume was more than three times the daily average of around 3.6 million shares. The company had no specific news Tuesday. About half an hour before the closing bell the stock traded up about 2% for the day.

  • [By Logan Wallace]

    Bowling Portfolio Management LLC lifted its position in shares of MGIC Investment Corp. (NYSE:MTG) by 17.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 216,375 shares of the insurance provider’s stock after buying an additional 31,473 shares during the period. Bowling Portfolio Management LLC’s holdings in MGIC Investment were worth $2,320,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Safest Stocks To Own Right Now: Corporate Office Properties Trust(OFC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media headlines about Corporate Office Properties Trust (NYSE:OFC) have been trending somewhat positive on Sunday, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Corporate Office Properties Trust earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned news headlines about the real estate investment trust an impact score of 45.8310227240563 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Motley Fool Transcribers]

    Corporate Office Properties Trust  (NYSE:OFC)Q4 2018 Earnings Conference CallFeb. 08, 2019, 12:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    TRADEMARK VIOLATION NOTICE: “Blueshift Asset Management LLC Buys New Position in Corporate Office Properties Trust (OFC)” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/4200816/blueshift-asset-management-llc-buys-new-position-in-corporate-office-properties-trust-ofc.html.

Top 10 Medical Stocks To Buy Right Now

Small cap Internet of Medical Things (IoMT) company Biotricity, Inc (OTCBB: BTCY) has just announced that it will be expanding the scope of a previously approved clinical investigation of fetal heart rate variability (fHRV) to include maternal HRV and other key physiologic metrics for maximum predictive accuracy and efficiency. This is potentially a good area to be in due to the fact that high-risk pregnancies require extensive monitoring and care during the gestational period. High-risk pregnancies are also on the rise and now account for 6 – 8% of all pregnancies in the U.S. due in part to a rise in existing maternal health conditions (such as high blood pressure and obesity) and older parental age at the time of pregnancy. This means that the maternal and fetal monitoring market is growing rapidly and is expected to be worth $2.3 Billion by 2019. 

Top 10 Medical Stocks To Buy Right Now: Pimco Corporate & Income Stategy Fund(PCN)

Advisors’ Opinion:

  • [By Shane Hupp]

    PeepCoin (PCN) uses the hashing algorithm. Its launch date was September 26th, 2016. PeepCoin’s total supply is 56,576,323,977 coins and its circulating supply is 17,376,323,977 coins. PeepCoin’s official website is dapscoin.com. The official message board for PeepCoin is medium.com/dapscoinofficial. PeepCoin’s official Twitter account is @DAPScoin and its Facebook page is accessible here. The Reddit community for PeepCoin is /r/DAPSCoin.

  • [By Max Byerly]

    PeepCoin (CURRENCY:PCN) traded down 16.9% against the U.S. dollar during the 24 hour period ending at 23:00 PM Eastern on July 9th. During the last week, PeepCoin has traded 35.9% lower against the U.S. dollar. One PeepCoin coin can currently be bought for $0.0000 or 0.00000001 BTC on popular exchanges including Cryptohub, TradeOgre, Bleutrade and C-Patex. PeepCoin has a total market cap of $619,022.00 and approximately $25,154.00 worth of PeepCoin was traded on exchanges in the last 24 hours.

  • [By Ethan Ryder]

    News stories about PIMCO Corporate & Income (NYSE:PCN) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. PIMCO Corporate & Income earned a news impact score of 0.05 on Accern’s scale. Accern also gave news articles about the investment management company an impact score of 46.3242910143552 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Joseph Griffin]

    PeepCoin (CURRENCY:PCN) traded 70.2% higher against the dollar during the 24-hour period ending at 13:00 PM ET on August 14th. During the last week, PeepCoin has traded 1.4% higher against the dollar. One PeepCoin coin can currently be bought for $0.0000 or 0.00000000 BTC on popular cryptocurrency exchanges including Trade Satoshi, CoinExchange, C-Patex and Cryptopia. PeepCoin has a total market cap of $497,805.00 and $5,648.00 worth of PeepCoin was traded on exchanges in the last 24 hours.

Top 10 Medical Stocks To Buy Right Now: Aluminum Corporation of China Ltd(ACH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Aluminum Corp. of China Limited (NYSE:ACH) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $10.70 and last traded at $10.71, with a volume of 2367 shares trading hands. The stock had previously closed at $11.00.

  • [By Max Byerly]

    Aluminum Corp. of China Limited (NYSE:ACH) has received an average rating of “Hold” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company.

  • [By Jon C. Ogg]

    Aluminum Corp. of China Ltd. (NYSE: ACH) was trading up over 7% at $11.88 in New York trading. The 52-week range is $9.20 to $23.54.

    Century Aluminum Co. (NASDAQ: CENX) was down 13.3% at $10.30, and it now has a new 52-week range of $10.13 to $24.77, with that low being put in on the same day.

  • [By Logan Wallace]

    Banco de Sabadell S.A acquired a new position in Aluminum Corp. of China Limited (NYSE:ACH) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 25,227 shares of the basic materials company’s stock, valued at approximately $340,000.

  • [By Ethan Ryder]

    Aluminum Corp. of China Limited (NYSE:ACH) has been assigned a consensus recommendation of “Hold” from the eight research firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company.

  • [By Max Byerly]

    Aluminum Corp. of China Limited (NYSE:ACH) has been assigned an average recommendation of “Hold” from the seven ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company.

Top 10 Medical Stocks To Buy Right Now: Minerva Neurosciences, Inc(NERV)

Advisors’ Opinion:

  • [By Max Byerly]

    Minerva Neurosciences (NASDAQ:NERV) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

    Nuvectra (NASDAQ:NVTR) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

  • [By Shane Hupp]

    AnaptysBio (NASDAQ: NERV) and Minerva Neurosciences (NASDAQ:NERV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

  • [By Lisa Levin] Gainers
    Carver Bancorp, Inc. (NASDAQ: CARV) shares jumped 92.1 percent to $7.01.
    iPic Entertainment Inc. (NASDAQ: IPIC) gained 21.6 percent to $9.73.
    Baozun Inc. (NASDAQ: BZUN) shares jumped 18.7 percent to $53.49 after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) shares jumped 15.9 percent to $50.50. The company's "Smackdown Live" may not be renewed at NBCUniversal network and the company's "Monday Night Raw" program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter.
    Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) gained 14.7 percent to $ 20.46 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) climbed 13.4 percent to $5.5009.
    Endocyte, Inc. (NASDAQ: ECYT) rose 13.3 percent to $ 14.23 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting.
    Diana Containerships Inc. (NASDAQ: DCIX) gained 12.9 percent to $1.7499 after the company announced the sale of Post-Panamax Container Vessel for $21 million.
    Essendant Inc. (NASDAQ: ESND) gained 12.7 percent to $12.43. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash.
    Blink Charging Co (NASDAQ: BLNK) rose 11.8 percent to $8.04 after surging 31.68 percent on Wednesday.
    OptimumBank Holdings, Inc. (NASDAQ: OPHC) gained 11.5 percent to $5.15.
    Flotek Industries, Inc. (NYSE: FTK) shares climbed 10.7 percent to $3.74.
    Farmer Bros. Co. (NASDAQ: FARM) rose 7.9 percent to $25.95 after climbing 7.90 percent on Wednesday.
    Minerva Neurosciences Inc (NASDAQ: NERV) rose 6.5 percent to $6.93 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients.
    Williams Partners L.P. (NYSE: WPZ) rose 5.6 percent to $40

Top 10 Medical Stocks To Buy Right Now: Helen of Troy Limited(HELE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Helen of Troy Limited (NASDAQ:HELE) have been assigned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $115.75.

  • [By Motley Fool Staff]

    Helen of Troy Limited (NYSE: HELE)Q1 2019 Helen Of Troy Limited Earnings Conference callJul. 09, 2018, 1:00 pm ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Steve Symington]

    Shares of Helen of Troy Limited (NASDAQ:HELE) climbed 12.7% on Monday after the consumer brand housewares, health, home, and beauty products company announced strong fiscal first-quarter 2019 results.

  • [By Shane Hupp]

    Helen of Troy (NASDAQ:HELE) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Saturday.

  • [By Logan Wallace]

    Helen of Troy (NASDAQ:HELE) issued its quarterly earnings data on Tuesday. The company reported $1.98 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.59 by $0.39, Bloomberg Earnings reports. The firm had revenue of $393.50 million during the quarter, compared to analyst estimates of $349.19 million. Helen of Troy had a return on equity of 19.01% and a net margin of 4.84%. The business’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.65 earnings per share. Helen of Troy updated its FY 2019 guidance to $7.65-7.90 EPS and its FY19 guidance to $7.65-7.90 EPS.

Top 10 Medical Stocks To Buy Right Now: Ionis Pharmaceuticals, Inc.(IONS)

Advisors’ Opinion:

  • [By Cory Renauer]

    Although Spinraza’s trajectory could quickly reverse, Biogen made a smart move by expanding its investment into the company that discovered it, Ionis Pharmaceuticals (NASDAQ:IONS). Unfortunately, Ionis probably won’t be adding any candidates to Biogen’s ultra-risky late-stage pipeline right away.

  • [By Chris Lange]

    Akcea Therapeutics Inc. (NASDAQ: AKCA) shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) that they had received a marketing authorization approval from the European Commission (EC).

  • [By Cory Renauer]

    This Ionis Pharmaceuticals (NASDAQ:IONS) spinoff earned approval to market a rare disease drug called Tegsedi in the European Union earlier this year, but the U.S. Food and Drug Administration (FDA) won’t make a decision about the drug we also know as inotersen until October. In the meantime, the agency is expected to deliver an approval decision on or before August 30 for Waylivra, formerly volanesorsen, and the outcome is far from certain.

  • [By Dan Caplinger]

    Tuesday turned out to be a relatively quiet session on Wall Street, as the S&P 500 and other major benchmarks made modest gains to continue their impressive summer rally. Between favorable economic data and continued confidence in the lasting power of a bull market that’s approaching its 10th anniversary, investors seem inclined to accentuate the positive and ignore worries about future setbacks. Yet a few stocks did lose ground due to bad news affecting individual companies. Canopy Growth (NYSE:CGC), Mitek Systems (NASDAQ:MITK), and Ionis Pharmaceuticals (NASDAQ:IONS) were among the performers in the market. Here’s why they did so poorly.

Top 10 Medical Stocks To Buy Right Now: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Chris Lange]

    Juniper Pharmaceuticals Inc. (NASDAQ: JNP) shares rallied early on Tuesday after the company announced that it would be acquired by Catalent. The transaction is expected to close in the third quarter of 2018.

Top 10 Medical Stocks To Buy Right Now: Points International, Ltd.(PCOM)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about Points International (NASDAQ:PCOM) (TSE:PTS) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Points International earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news articles about the information services provider an impact score of 48.0880042366604 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Joseph Griffin]

    Royal Bank of Canada reiterated their buy rating on shares of Points International (NASDAQ:PCOM) (TSE:PTS) in a report issued on Thursday morning. The brokerage currently has a $19.00 target price on the information services provider’s stock, up from their prior target price of $17.00.

  • [By Max Byerly]

    Points International Ltd. (NASDAQ:PCOM) (TSE:PTS) hit a new 52-week high and low on Wednesday . The stock traded as low as $15.08 and last traded at $15.00, with a volume of 402 shares traded. The stock had previously closed at $14.91.

  • [By Logan Wallace]

    Points International Ltd. (TSE:PTS) (NASDAQ:PCOM) insider Inez Mary Christine Murdoch sold 2,726 shares of the stock in a transaction dated Friday, June 29th. The stock was sold at an average price of C$21.12, for a total transaction of C$57,573.12.

Top 10 Medical Stocks To Buy Right Now: Targa Resources, Inc.(TRGP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    There’s just one problem with all that production: It needs to get out of the basin, which is a problem right now since there aren’t enough pipelines. Because of that, some of the best ways to play the Permian production boom are pipeline companies. Three perfectly positioned to profit from the Permian boom are Plains All American Pipeline (NYSE:PAA), Targa Resources (NYSE:TRGP), and Kinder Morgan (NYSE:KMI).

  • [By Matthew DiLallo]

    Meanwhile, Targa Resources (NYSE:TRGP) has been targeting investment opportunities focused on natural gas and NGLs and currently has more than $2 billion in projects under way. The company is one of the partners on Kinder Morgan’s Gulf Coast Express pipeline as well as on the proposed Whistler project that would also move gas out of the Basin. In addition to that, Targa is building the Grand Prix Pipeline, which will transport NGLs out of both the Permian and STACK shale play. These projects have the potential to nearly double Targa’s earnings by 2021.

  • [By Lee Jackson]

    This top energy MLP has had a string of positives lately. Targa Resources Corp (NYSE: TRGP) is a leading provider of midstream services and is one of the largest independent midstream energy companies in North America. Targa owns, operates, acquires and develops a diversified portfolio of complementary midstream energy assets.

  • [By Joseph Griffin]

    Shares of Targa Resources Corp (NYSE:TRGP) have been assigned a consensus rating of “Hold” from the twenty-four research firms that are covering the firm, MarketBeat Ratings reports. Thirteen investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month target price among brokers that have covered the stock in the last year is $55.63.

  • [By Matthew DiLallo]

    Targa Resources (NYSE:TRGP) currently offers a well-above-average dividend that yields 6.6%. In exchange for that high yield, investors need to accept a higher level of risk since the company barely generates enough cash flow to cover that payout, which is one of several red flags.

Top 10 Medical Stocks To Buy Right Now: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    According to a recent report by Reuters, ConocoPhillips (NYSE:COP) has held talks with investment banks about helping the company unload its stake in Cenovus Energy (NYSE:CVE). That sale could net the oil giant more than $2 billion in cash, which would bolster its already sizable cash war chest and give it more money to allocate in creating value for investors.

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short rose slightly to 21.33 million from the previous level of 21.01 million. Shares were trading at $64.79, within a 52-week range of $42.27 to $71.71.

  • [By Joseph Griffin]

    10 15 Associates Inc. lowered its holdings in ConocoPhillips (NYSE:COP) by 1.3% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 207,906 shares of the energy producer’s stock after selling 2,741 shares during the period. ConocoPhillips makes up 2.9% of 10 15 Associates Inc.’s holdings, making the stock its 8th biggest holding. 10 15 Associates Inc.’s holdings in ConocoPhillips were worth $12,327,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Buy Right Now: National Western Life Group, Inc.(NWLI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    National Western Life Group (NASDAQ:NWLI) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Friday.

  • [By Logan Wallace]

    National Western Life (NASDAQ: NWLI) and Brighthouse Financial (NASDAQ:BHF) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

  • [By Stephan Byrd]

    Millennium Management LLC trimmed its holdings in shares of National Western Life Group Inc (NASDAQ:NWLI) by 64.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,115 shares of the financial services provider’s stock after selling 1,993 shares during the period. Millennium Management LLC’s holdings in National Western Life Group were worth $340,000 as of its most recent filing with the SEC.

Hot Medical Stocks To Invest In 2019

Mettler Toledo (NYSE:MTD) announced its earnings results on Thursday. The medical instruments supplier reported $3.74 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.73 by $0.01, Bloomberg Earnings reports. Mettler Toledo had a return on equity of 93.09% and a net margin of 13.50%. The company had revenue of $660.82 million for the quarter, compared to analyst estimates of $651.87 million. During the same period in the prior year, the company posted $3.34 EPS. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. Mettler Toledo updated its Q2 guidance to $4.55 to $4.60 EPS.

Shares of MTD stock opened at $552.97 on Friday. The company has a current ratio of 1.46, a quick ratio of 1.09 and a debt-to-equity ratio of 1.75. The stock has a market capitalization of $14,641.79, a PE ratio of 31.47, a PEG ratio of 2.20 and a beta of 1.21. Mettler Toledo has a fifty-two week low of $540.78 and a fifty-two week high of $697.26.

Hot Medical Stocks To Invest In 2019: GTT Communications, Inc.(GTT)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

    Get GTT Communications alerts:

    GTT to Present at Spring 2018 Investor Conferences (finance.yahoo.com) Unified Communications Week in Review: Firstcom, 8×8, RingCentral (unified-communications.tmcnet.com) RingCentral, SD-WAN vendors team up to deliver UCaaS (searchunifiedcommunications.techtarget.com) GTT Communications (GTT) CEO Richard Calder Sells 6,000 Shares (americanbankingnews.com) GTT Communications (GTT) EVP Chris Mckee Sells 7,000 Shares (americanbankingnews.com)

    GTT has been the topic of several recent research reports. Oppenheimer increased their price objective on GTT Communications from $52.00 to $68.00 in a research report on Tuesday, February 27th. William Blair reiterated a “buy” rating on shares of GTT Communications in a research report on Wednesday, March 28th. Craig Hallum reiterated a “buy” rating and set a $60.00 price objective (up from $50.00) on shares of GTT Communications in a research report on Monday, February 26th. SunTrust Banks increased their price objective on GTT Communications to $60.00 and gave the company a “buy” rating in a research report on Friday, March 2nd. Finally, Jefferies Group increased their price objective on GTT Communications to $62.00 and gave the company a “buy” rating in a research report on Friday, March 2nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $57.22.

  • [By ]

    In the Lightning Round, Cramer was bullish on GTT Communications (GTT) , Steel Dynamics (STLD) , Nucor (NUE) , Marriott International (MAR) , MGM Resorts (MGM) and Twitter (TWTR) .

  • [By Lisa Levin]

    Analysts at KeyBanc upgraded GTT Communications, Inc. (NYSE: GTT) from Sector Weight to Overweight.

    GTT Communications shares fell 0.64 percent to $46.35 in pre-market trading.

  • [By ]

    GTT Communications (GTT) : “I think they have a great business model. I say buy, buy, buy.”

    Steel Dynamics (STLD) : “That’s a great steel company and the only one I’ll recommend other than Nucor (NUE) .”

Hot Medical Stocks To Invest In 2019: AMERISAFE, Inc.(AMSF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub lowered shares of AMERISAFE (NASDAQ:AMSF) from a hold rating to a sell rating in a report released on Friday.

    Other research analysts have also issued reports about the stock. TheStreet raised shares of AMERISAFE from a c+ rating to a b rating in a report on Thursday, April 26th. ValuEngine raised shares of AMERISAFE from a hold rating to a buy rating in a report on Thursday, March 1st. Boenning Scattergood reaffirmed a hold rating on shares of AMERISAFE in a report on Tuesday, February 27th. Keefe, Bruyette & Woods initiated coverage on shares of AMERISAFE in a report on Thursday, April 5th. They issued a market perform rating and a $54.00 price target for the company. Finally, Zacks Investment Research lowered shares of AMERISAFE from a hold rating to a strong sell rating in a report on Tuesday, March 6th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company’s stock. AMERISAFE currently has a consensus rating of Hold and a consensus target price of $63.00.

  • [By Shane Hupp]

    Amerisafe, Inc. (NASDAQ:AMSF) EVP Vincent J. Gagliano sold 249 shares of Amerisafe stock in a transaction that occurred on Tuesday, May 22nd. The shares were sold at an average price of $60.15, for a total value of $14,977.35. Following the transaction, the executive vice president now owns 17,178 shares of the company’s stock, valued at $1,033,256.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “$0.73 Earnings Per Share Expected for Amerisafe, Inc. (AMSF) This Quarter” was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at www.tickerreport.com/banking-finance/3362844/0-73-earnings-per-share-expected-for-amerisafe-inc-amsf-this-quarter.html.

Hot Medical Stocks To Invest In 2019: Houston Wire & Cable Company(HWCC)

Advisors’ Opinion:

  • [By Max Byerly]

    Houston Wire & Cable (NASDAQ:HWCC) hit a new 52-week high and low during mid-day trading on Wednesday after an insider bought additional shares in the company. The stock traded as low as $8.40 and last traded at $8.35, with a volume of 604 shares traded. The stock had previously closed at $7.90.

Hot Medical Stocks To Invest In 2019: Ionis Pharmaceuticals, Inc.(IONS)

Advisors’ Opinion:

  • [By Brian Orelli]

    Pfizer (NYSE:PFE) threw Alnylam and fellow ATTR drugmaker Ionis Pharmaceuticals (NASDAQ:IONS) a curveball in March, releasing positive results from a trial testing its ATTR drug tafamidis in patients with ATTR cardiomyopathy. But Alnylam isn’t backing down with potential plans to run a trial comparing its next-generation TTR drug, ALN-TTRsc02, against tafamidis, as outlined by Akshay Vaishnaw, Alnylam’s executive vice president of research and development:

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    With that in mind, we asked a team of Motley Fool investors to highlight a biotech stock that they think is a strong buy right now. Here’s why they picked Exelixis (NASDAQ:EXEL), Celgene (NASDAQ:CELG), and Ionis Pharmaceuticals (NASDAQ:IONS).

  • [By Cory Renauer]

    Although Spinraza’s trajectory could quickly reverse, Biogen made a smart move by expanding its investment into the company that discovered it,Ionis Pharmaceuticals(NASDAQ:IONS). Unfortunately, Ionis probably won’t be adding any candidates to Biogen’s ultra-riskylate-stage pipeline right away.

  • [By Chris Lange]

    Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares made a handy gain on Friday after the firm announced an expanded strategic collaboration with Biogen Inc. (NASDAQ: BIIB). Through this partnership, these companies are planning to tackle and develop novel antisense drug candidates for a broad range of neurological diseases.

Hot Medical Stocks To Invest In 2019: Smith & Nephew SNATS, Inc.(SNN)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Benzinga News Desk]

    Weight Watchers (NYSE: WTW) is tipping the scales on Wall Street: Link

    ECONOMIC DATA
    USA Nonfarm Payrolls for Apr 164.0K vs 189.0K Est; Prior 103.0K. Private Payrolls for Apr 168.0K vs 194.0K Est; Prior 102.0K
    Unemployment Rate for Apr 3.90% vs 4.00% Est; Prior 4.10%
    New York Fed President William Dudley is set to speak at 12:45 p.m. ET.
    The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
    Federal Reserve Bank of San Francisco President John Williams will speak at 3:00 p.m. ET.
    Randal Quarles, Vice Chairman for Supervision, is set to speak at 5:30 p.m. ET.
    Dallas Fed President Robert Kaplan will speak at 8:00 p.m. ET.
    Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 8:00 p.m. ET.
    Kansas City Fed President Esther George will speak at 8:00 p.m. ET.
    ANALYST RATINGS
    RBC upgraded Benefitfocus (NASDAQ: BNFT) from Sector Perform to Outperform
    Stephens upgraded FMC (NYSE: FMC) from Equal-Weight to Overweight
    RBC downgraded Colfax (NYSE: CFX) from Outperform to Sector Perform
    Deutsche Bank downgraded Smith & Nephew (NYSE: SNN) from Hold to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top Stocks To Invest In Right Now

5 More Aetna-CVS Deal Details, from Aetna’s SEC Filings

‘Leave Your Checkbook at Home’: New Seminar Alert Update

America’s Retirement System Is Too Inconsistent

Americo Financial Life and Annuity Insurance Company has introduced an unusual product: a single-premium long-term care insurance (LTCI) policy aimed at people who already need long-term care (LTC) services.

Americo has designed the new Reliable Living Plan policy to provide a monthly cash indemnity benefit as long as an eligible insured needs qualified LTC services.

(Related: Saving LTCI and 9 Other Top Treasury Life and Annuity Projects)

To be eligible to have the policy, and to get the benefits, policyholder must be age 65 or older. The policyholder also must already need substantial assistance with at least two “activities of daily living,” or need substantial supervision due to dementia or some other form of cognitive impairment.

The kinds of LTC services that count as “qualified LTC services” include home health care, adult day care, assisted living care and nursing home care.

Top Stocks To Invest In Right Now: Markel Corporation(MKL)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Markel (NYSE:MKL) has been referred to as a mini-Berkshire many times, and for good reason. The company uses the same general business model as Warren Buffett does at Berkshire, using the cash from its insurance businesses to buy stocks and entire companies.

  • [By Ashley Moore]

    Here is a table of the 10 most expensive stocks trading on U.S. markets today:

    Company (Ticker)Price per ShareMarket CapBerkshire Hathaway Inc. (NYSE: BRK-A)$ 257,227.52$ 419.50 billionSeaboard Corp. (NYSEMKT: SEB)$ 3,760.00$ 4.48 billionNVR Inc. (NYSE: NVR)$ 1,944.23$ 7.19 billionThe Priceline Group Inc. (Nasdaq: PCLN)$ 1,727.94$ 80.82 billionMarkel Corp. (NYSE: MKL)$ 978.51$ 13.78 billionWhite Mountains Insurance Group Ltd. (NYSE: WTM)$ 935.01$ 4.25 billionAmazon.com Inc. (Nasdaq: AMZN)$ 846.08$ 408.27 billionAlphabet Inc. (Nasdaq: GOOGL)$ 844.06$ 582.85 billionAutoZone Inc. (NYSE: AZO)$ 744.26$ 21.04 billionIntuitive Surgical Inc. (Nasdaq: ISRG)$ 735.63$ 28.41 billion

  • [By Andy Pai]

    Akre capital often holds positions for over ten years. As long as a company is able to keep increasing its economic value, the firm will hold a stock. Although the firm is a long-term investor, Akre doesn't attribute its success to ‘buy and hold' investing, but to the quality of the companies they buy. Some of the companies' long-term holdings have included Markel Corporation (NYSE: MKL), Dollar Tree, Inc. (NASDAQ: DLTR) and Enstar Group Ltd. (NASDAQ: ESGR).

Top Stocks To Invest In Right Now: NetApp Inc.(NTAP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Analysts at Piper Jaffray upgraded NetApp Inc. (NASDAQ: NTAP) from Neutral to Overweight and raised the price target from $37.00 to $46.00.

    NetApp shares rose 0.33 percent to close at $39.58 on Monday.

  • [By WWW.THESTREET.COM]

    NetApp (NTAP) was upgraded to buy from hold at Drexel Hamilton. $52 price target. The company continues to execute a successful business transition, Drexel said. 

  • [By Lisa Levin]

    Breaking news

    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday.
    Helmerich & Payne, Inc. (NYSE: HP) posted upbeat results for its fourth quarter.
    NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance.
    Emerson Electric Co. (NYSE: EMR) proposed to acquire Rockwell Automation (NYSE: ROK) for $225 per share in cash and stock.

  • [By Matt Hogan]

    Apple EBITDA Margins vs Peers Chart Apple's EBITDA margins vs technology peers: Western Digital Corp. (NASDAQ: WDC), HP Inc. (NYSE: HPQ), Hewlett Packard Enterprise Co. (NYSE: HPE) and NetApp Inc. (NASDAQ: NTAP).

Top Stocks To Invest In Right Now: Ionis Pharmaceuticals, Inc.(IONS)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Here is a preview of the offerings set between June 27 and June 30.

    11 IPOs This Week Avenue Therapeutics, Inc. (ATXI) will issue 5 million shares between $5 and $7 Tuesday on the Nasdaq. A Fortress Biotech Inc (NASDAQ: FBIO) subsidiary, the pharmaceutical acquires, develops and commercializes products for in-hospital use, such as its post-operative palliative. Esquire Financial Holdings, Inc. (ESQ) will issue more than 2.36 shares between $14 and $16 Tuesday on the Nasdaq. The business-focused commercial bank has two locations in New York and Florida. Mersana Therapeutics, Inc. (MRSN) will issue 5 million shares between $14 and $16 Wednesday on the Nasdaq. The clinical-stage pharmaceutical specializes in immunoconjugate therapies targeting diverse forms of cancer. TPG Pace Holdings Corp. (TPGHU) will issue 40 million shares at $10 Wednesday on the New York Stock Exchange. Formed by TPG, the firm acquires relevant businesses and stocks across industries, from health care and digital media to real estate and energy. Aileron Therapeutics Inc (ALRN) will issue 3.75 million shares between $15 and $17 Thursday on the Nasdaq. The biopharmaceutical firm targets suppressor proteins to halt tumor progression. Blue Apron Holdings, Inc. (APRN) will issue 30 million shares between $15 and $17 Thursday on the NYSE. The meal-kit service delivers pre-portioned ingredients directly to the consumer. Byline Bancorp, Inc. (BY) will issue 5.7 million shares between $19 and $21 Thursday on the NYSE. The century-old commercial bank has more than 50 branches in the Chicago and Milwaukee areas with offices nationwide. Dova Pharmaceuticals, Inc.(DOVA) will issue more than 4.06 million shares between $15 and $17 Thursday on the Nasdaq. As a clinical-stage company, Dova acquires, develops and commercializes drug candidates for rare diseases. Tintri, Inc. (TNTR) will issue 8.7 million shares between $10.50 and $12.50 Thursday on the Nasdaq. With cloud management software, all-flash stor

  • [By Brian Orelli]

    Ionis Pharmaceuticals (NASDAQ:IONS) gave investors an update on its pipeline today with a slide deck that contained a whopping 65 entries. The whole presentation is worth a listen, but here are the five slides investors absolutely must see.

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

  • [By WWW.THESTREET.COM]

    Coming up in this episode of Mad Money: Cramer interviews Dr. Stanley Crooke, CEO of Ionis Pharmaceuticals (IONS) . And, here’s Cramer’s read on Trump’s view of China. Plus, don’t miss the Lightning Round. Which stocks in Cramer bullish on?

Top Stocks To Invest In Right Now: Resolute Energy Corporation(REN )

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    The activist hedge fund’s latest 13F revealed a stake in Resolute Energy Corp (NYSE: REN), and on Monday, it announced a new position in EQT Corporation (NYSE: EQT).

  • [By Ezra Schwarzbaum]

    Related Links: Magellan Midstream Riding The Wave Of Rising US Oil Exports

    Resolute Energy Corp (NYSE: REN), $40 Price Target

    Moving into the late-2014 downturn, Resolute had an over-levered balance sheet, flat production and a wide geographical spread.

  • [By WWW.THESTREET.COM]

    Or how about Resolute Energy (REN) , which has a big position in the Permian. Why is that stock not quitting? Same with Diamondback Energy (FANG) . How can that one keep roaring?

Top Stocks To Invest In Right Now: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Lisa Levin]

    Shares of Tandem Diabetes Care Inc (NASDAQ: TNDM) were down 58 percent to $2.25 after the company posted downbeat quarterly results.

    Cempra Inc (NASDAQ: CEMP) was down, falling around 59 percent to $7.69 after the FDA raised liver safety issues in its review of the company's experimental drug to treat community acquired pneumonia. Baird downgraded Cempra from Outperform to Underperform.

  • [By Lisa Levin]

    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares dropped 19 percent to $1.25. Tandem Diabetes Care priced its 18 million share offering at $1.25 per share.

  • [By Paul Ausick]

    Tandem Diabetes Care Inc. (NASDAQ: TNDM) dropped nearly 26% Thursday, to post a new 52-week low of $1.15 after closing at $1.55 on Wednesday. The stock’s 52-week high is $11.30. Volume was more than 20 times the daily average of around 290,000. The company announced an underwritten secondary offering of 18 million shares at $1.25 per share.